Vaso-occlusive Events
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients (NCT07752043) | Assistance Publique - Hôpitaux de Paris | 2026-09-01 |
Track Vaso-occlusive Events automatically
Every clearance here is in the API, with alerts when new ones post.